China's Pharmaceutical Intermediates Producers Plan US$1.88 Billion in Project Kickoffs for 2022
China's Pharmaceutical Intermediates Producers Plan US$1.88 Billion in Project Kickoffs for 2022
BEIJING--December 29, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--China's carbon neutrality and emissions policy has had an impact on a few of the country's chemical synthetic pharmaceutical plants, but that hasn't stopped plans for new projects.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
